Core A: Metabolomics Core

$218,444P01FY2014DKNIH

Washington University, Saint Louis MO

Investigators

Linked publications & trials

Paper 37372419 Paper 35533274 Paper 35258509 Paper 34163075 Paper 33684031 Paper 33571448 Paper 32365167 Paper 31831058 Paper 31585844 Paper 31539500 Paper 30443602 Paper 30273610 Paper 29719869 Paper 29515039 Paper 29476613 Paper 29181446 Paper 29073107 Paper 28841195 Paper 28799899 Paper 28684495 Paper 28289731 Paper 28144630 Paper 28094011 Paper 28041931 Paper 27911843 Paper 27760558 Paper 27178263 Paper 26406373 Paper 26344404 Paper 26299453 Paper 26257300 Paper 25815983 Paper 25795776 Paper 25770346 Paper 25766684 Paper 25576328 Paper 25307765 Paper 25284151 Paper 25170151 Paper 25036628 Paper 24950202 Paper 24452263 Paper 24259713 Paper 24009397 Paper 23975157 Paper 23898195 Paper 23828941 Paper 23363771 Paper 23202435 Paper 23184592 Paper 22980325 Paper 22864264 Paper 22699611 Paper 22678395 Paper 22665442 Paper 22424233 Paper 22402401 Paper 22179717 Paper 22170430 Paper 22161565 Paper 22030749 Paper 22018228 Paper 21903626 Paper 21765408 Paper 21677749 Paper 21624126 Paper 21596990 Paper 21593810 Paper 21543530 Paper 21530737 Paper 21485746 Paper 21436049 Paper 21317366 Paper 20944220 Paper 20818378 Paper 20674856 Paper 20664551 Paper 20631792 Paper 20444704 Paper 20383131 Paper 20363958 Paper 20197316 Paper 19892944 Paper 19710709 Paper 19706296 Paper 19491241 Paper 19383763 Paper 19279067 Paper 19099591 Paper 19046431 Paper 19043404 Paper 19026936 Paper 19004758 Paper 18806222 Paper 18723574 Paper 18555187 Paper 18541218 Paper 18497261 Paper 18407065 Paper 18280814

Abstract

SUMMARY The metabolomics core laboratory at the Duke Stedman Center deploys both targeted and non-targeted mass spectrometry (MS)-based metabolic profiling to provide a rare combination of broad coverage and analytical precision. The Duke team has been a leader in applying targeted MS-based metabolic profiling for understanding of disease and biological mechanisms. The role of the core in the current application will be to perform both targeted and non-targeted metabolomics assays on samples generated by Dr. Gordon in Project 1, and Drs. Heath and Klein in Project 2; in both instances this work continues previously established and productive collaborations between our groups. In the context of Project 1, Core A will measure metabolites produced by microbial communities taken from obese and lean twin pairs and transplanted into germ-free mice, and will also provide metabolomic profiles of serum, urine and tissues of the host animals. In the context of Project 2, Core A will provide metabolomic profiles of twin pairs with discordance for obesity that are further sub-divided into metabolically well and unwell subgroups. Obtaining metabolic profiles of the human subjects in collaboration with Project 2 provides a unique opportunity to investigate the impact of gut microbiota from those subjects on metabolism when transplanted into mice via Project 1. We hypothesize that disease-related metabolic signatures will be transmitted to germ-free mice by transplantation of microbial communities from obese and metabolically unhealthy subjects. Metabolic profiles of serum, urine and tissues will include targeted MS/MS and GC/MS-based assays of approximately 220 metabolites across 8 classes or modules of analytes that represent byproducts of core metabolic pathways. These analyses will be supplemented by non-targeted GC/MS-based analyses of a broader array of metabolites, including some unique to microbial metabolic pathways.

View original record on NIH RePORTER →